> CLINICAL RESULTS
Atoderm Intensive Eye applied daily, the product significantly increases the rate of cutaneous hydration by +66%* in 2 hours. This hydrating effect persists 24 hours after application with an increase in hydration by+20% *(1)
> ACTION ON CONTACT DERMATITIS
After 28 days of Atoderm Intensive Eye application (twice daily), the results show a significant decrease in: (2)
Skin dryness (-89%) **
Erythema (-93.3%) ***
Edema (-100%)
Desquamation (-100%) *
Roughness (-96%) ***
Tightness (-100%) ***
Stinging (-88%) *
Burning sensation (-100%) ***
Itching (-89%) **
The quality of life of patients was significantly improved on day 28 with a decrease by -57.7%*** in the SKINDEX-16 total score. (2)
> ACTION ON ALLERGEN PREVENTION & REMOVAL
Atoderm Intensive Eye is a good make-up cleanser as well as a good remover of accumulated pollen allergen(3).
A study was conducted on allergen accumulation:
Atoderm Intensive Eye was applied to a skin explant which was then subjected to very high allergen exposure. The study shows that the use of Atoderm Intensive Eye preserved the skin from the accumulation of the allergen in the infundibulum(3).
Moreover, cleansing with Atoderm Intensive Eye the skin explant that was exposed to allergen without using any product in prevention (+183% of allergen vs skin explant non exposed) allowed a strong elimination of the accumulation (-83%)*(3).
TOLERANCE
After 28 days, Atoderm Intensive Eye was very well tolerated by patients whether it was used alone or in combination with dermocorticoids(2,4)
*p<0.05 ** p<0.01 *** p<0.001, Student’s t-test, after 28 days
> PATIENT FEEDBACKS
For 82% to 98% of patients, Atoderm Intensive Eye is effective in many aspects: lastingly repairs and hydrates, cleanses and removes makeup from irritated eyelids, and eyelids that are more resistant to aggressions.(5)
(1) Consumer test on 105 volunteers aged 25 to 51, with dry to sensitive skin, twice-daily for 14 days.
(2) Clinical study on 33 subjects aged 22 to 83, with sensitive skin, 85% having dry skin, 15% having combination skin. Study under dermocorticoïds, for 9 to 32 days.
(3) Corneometry test on 10 volunteers aged 43 to 67, for 24 hours.